about
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitorsMutational evolution in a lobular breast tumour profiled at single nucleotide resolutionPreparation and analysis of microRNA libraries using the Illumina massively parallel sequencing technology.Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing.BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapyIdentification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.Whole-Organism Developmental Expression Profiling Identifies RAB-28 as a Novel Ciliary GTPase Associated with the BBSome and Intraflagellar Transport.Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.Enhancing knowledge discovery from cancer genomics data with Galaxy.LongSAGE profiling of nine human embryonic stem cell lines.Analysis of FOXO1 mutations in diffuse large B-cell lymphomaRecurrent targets of aberrant somatic hypermutation in lymphoma.Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencingPhase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.Newly identified mechanisms in B-cell non-Hodgkin lymphomas uncovered by next-generation sequencing.Recurrent genomic rearrangements in primary testicular lymphoma.Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies.FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor.Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas.An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup.Genome-wide chemical mapping of O-GlcNAcylated proteins in Drosophila melanogaster.Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.Cross-cancer profiling of molecular alterations within the human autophagy interaction network.Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation.Methods for sample acquisition and processing of serial blood and tumor biopsies for multicenter diffuse large B-cell lymphoma clinical trials.Genomic analysis of a rare human tumor.Immunogenicity of recurrent mutations in MYD88 and EZH2 in non-Hodgkin lymphomas.Management and visualization of whole genome shotgun assemblies using SAM.Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphomaMutation ofFOXL2in Granulosa-Cell Tumors of the OvaryToward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T CellsALEXA: a microarray design platform for alternative expression analysis
P50
Q21184033-84131920-9175-4298-901F-334D813448F3Q29619477-33E7F133-4E14-41FB-B845-086C46944AB6Q33649969-D863CB1D-C9DB-454F-BDC6-DD9EBDFA9659Q34012676-A027FDEC-CC46-495A-9CBA-8CC262518A74Q34360164-87A528D2-EB54-47C6-86C8-87D11F25C722Q35011883-97F29B3B-471E-4DAD-8D93-98A4E0A7F3B3Q35021337-01CBB0C7-3CA0-4B2C-AF94-A26538EDF082Q36215907-9313F24D-BC4C-482C-8448-D26935B8950CQ36222155-82781F50-3C74-4A7D-9808-DBF158A1D117Q36317809-BC09FCCC-C4B6-4A83-8EBA-4D0F7C52F74AQ36672391-30AF2781-59AE-4424-A3CD-A99856CE7CB5Q36814631-323E01FF-7559-4617-9585-F798B11DB35FQ37030889-836D178A-31A4-4320-8576-E383359AA613Q37098851-E4C23E32-9C68-47E5-AA39-35BCE3EC11EAQ37150016-CAB888BB-7D33-4DA0-B1B2-E9433F9E2797Q37210452-7E83C32C-FA2A-4013-A9D5-911080A31BD1Q37636976-B4CDF88F-0CA2-46D1-8843-B113799748B4Q38163705-914D5C8B-86E8-4EAC-BB10-C6680F4F8AE0Q38387704-7CB8FEF8-5623-4DFF-B8B7-B251F42711ABQ38390077-6005D962-2816-404F-ABE5-D67523525E8BQ38733229-2B58FDF7-3156-46DC-9531-5F0497AA6202Q38739035-F2CB440E-D139-405E-858B-67DA7E9CE2ABQ38766233-C2AC9444-E440-438D-8CA6-FA5F5516E3B1Q38940501-32B6206E-0909-44EE-9A49-5FA7F074ED94Q39130339-BF94AD19-0691-48CE-ABC2-FC731D24BC7BQ40391622-FFF1A962-A4B5-45BB-B8D9-1A3DFB961867Q40457005-C520391A-15F9-4B07-A0C1-23AF8556B7CBQ40698951-CC02785A-049C-46D1-965C-08C62C28EB36Q41066322-47FF09D7-3040-4882-BA3A-35F212464144Q42390872-FC60F15A-731B-42EA-B30E-DE9DCC5F8640Q44094833-D0BA3804-EC9B-459C-A188-B99FF80E4D1AQ45891314-23C133B3-408E-437D-BB5F-5E7013001CF3Q45921596-52D0EE6C-63E1-4600-8413-A74114CD1E31Q48134673-2616CC06-2A0F-4C10-B980-FDFE27A7192BQ48177867-4682634A-CAA7-4FC6-9E61-E77DB11D5889Q48248863-2C9ECA39-2533-49FA-A172-0158605B0E6CQ57059909-F1C50CDB-3CBE-4F11-82E5-D458847677F3Q57287268-FAF31D0B-7328-48EA-A94D-FF2B2C7B59C8Q57443466-D9A3FFA6-93CC-4FF5-BFA1-BDD0971301F1Q57903523-6CDE0064-FAEA-4A60-B7C6-2FF78D9151BE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ryan D Morin
@ast
Ryan D Morin
@en
Ryan D Morin
@es
Ryan D Morin
@nl
Ryan D Morin
@sl
type
label
Ryan D Morin
@ast
Ryan D Morin
@en
Ryan D Morin
@es
Ryan D Morin
@nl
Ryan D Morin
@sl
altLabel
Ryan Morin
@en
prefLabel
Ryan D Morin
@ast
Ryan D Morin
@en
Ryan D Morin
@es
Ryan D Morin
@nl
Ryan D Morin
@sl
P106
P21
P31
P496
0000-0003-2932-7800